- This company, formed in 2019, and based out of Rhode Island, U.S., is a biopharma company that went public through a reverse merger of Aesther Healthcare Acquisition Corp. – a Special Purpose Acquisition Company (“SPAC”) formed to acquire a company seeking to go public. SPACs gained popularity in 2020/2021 as a faster/cheaper route for private companies to go public.
- This report is currently available to premium subscribers – Free subscribers will gain access on Mar 22nd, 2022 Join as a FREE member and get our research report delivered straight to your inbox, with a seven-day delay
Visit Ocean Biomedical, Inc. page for more research, discussion boards and to like, and share.
Are you enjoying the highlights?
Discover the company's fair value estimate from our certified analysts, identify potential risks, and explore exciting upcoming catalysts in our detailed report.